Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: Voller Fokus auf NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

Portfolio Restructuring, Milestones, Earnings Releases and Schedules, and Collaborations - Analyst Notes on Novartis, Lockheed Martin, Raytheon, NVR and Gap

NEW YORK, April 24, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Novartis AG (NYSE: NVS), Lockheed Martin Corporation (NYSE: LMT), Raytheon Co. (NYSE: RTN), NVR Inc. (NYSE: NVR) and Gap Inc. (NYSE: GPS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1548-100free.

NovartisAG Analyst Notes
On April 22, 2014, Novartis AG (Novartis) announced a major portfolio restructuring, involving exchange of certain assets with GlaxoSmithKline plc (GSK) and divesture of its Animal Health Division to Eli Lilly and Company (Lilly), to increase its focus on leading businesses of innovative pharmaceuticals, eye care and generics. Novartis stated that it has agreed to acquire GSK oncology products for $14.5 billion, while divesting its vaccines business to GSK for $7.1 billion plus royalties. The two companies have also agreed to combine their consumer businesses through a joint venture between Novartis OTC and GSK Consumer Healthcare. In a separate transaction, Novartis has agreed to divest its Animal Health Division to Lilly for approximately $5.4 billion. The transaction with Lilly is expected to close by the end of Q1 2015 and the transaction with GSK is expected to close during H1 2015. Novartis' ADR ended higher by 1.29% at $86.56. The full analyst notes on Novartis are available to download free of charge at:

http://www.analystsreview.com/1548-NVS-24Apr2014.pdf

Lockheed Martin Corporation Analyst Notes
On April 21, 2014, Lockheed Martin Corporation (Lockheed Martin) announced that its Joint Light Tactical Vehicle (JLTV) has achieved 100,000 miles in the Government's Engineering & Manufacturing Development (EMD) reliability, availability and maintainability (RAM) testing. In August 2013, Lockheed Martin delivered 22 JLTVs to the U.S. Army and Marine Corps for EMD testing, which will continue through the fall. Scott Greene, VP of Ground Vehicles for Lockheed Martin Missiles and Fire Control, said, "Our JLTV continues to demonstrate excellent reliability. With this 100,000-mile milestone now in our rear-view mirror, we look forward to continue proving to our Army and Marine Corps customers that our JLTV delivers the most capability at the right price." The full analyst notes on Lockheed Martin are available to download free of charge at:

http://www.analystsreview.com/1548-LMT-24Apr2014.pdf

Raytheon Co. Analyst Notes
On April 15, 2014, Raytheon Co. (Raytheon) announced that it will issue its Q1 2014 earnings release on April 24, 2014 at 7 a.m. EDT, which will be followed by a conference call the same day at 9 a.m. EDT. On average, analysts polled by Bloomberg expect the Company's Q1 2014 EPS to rise to $1.76 from $1.56 in Q1 2013. In Q4 2013, Raytheon had reported EPS at $1.58, outpacing the Bloomberg's consensus estimate of $1.35. The full analyst notes on Raytheon are available to download free of charge at:

http://www.analystsreview.com/1548-RTN-24Apr2014.pdf

NVR Inc. Analyst Notes
On April 21, 2014, NVR, Inc. (NVR) released its Q1 2014 financial results and disappointed the street by posting a decline in its net income to $23.8 million, or $5.16 per diluted share, from $35.0 million, or $6.84 per diluted share, in Q1 2013. Analysts polled by Bloomberg had expected the Company's EPS at $9.69. NVR's stock fell 4.13% to close at $1,070.54 following the announcement. The decline in NVR's bottom-line during Q1 2014 was mainly due to increased competition in mortgage lending market which led to reduced loan profitability. Operating income for the mortgage banking operations during Q1 2014 decreased 91% YoY to $991,000. Consolidated revenues for the Q1 2014 totaled $811.3 million, a 5.33% increase from $770.3 million for Q1 2013. The full analyst notes on NVR are available to download free of charge at:

http://www.analystsreview.com/1548-NVR-24Apr2014.pdf

Gap Inc. Analyst Notes
On April 21, 2014, Gap Inc. (Gap) announced that Banana Republic, a division of Gap Inc., and celebrated designer Roland Mouret have launched the Roland Mouret for Banana Republic Collection. According to the Company, the collection highlights Mouret's keen understanding of fit and the female form through the use of Banana Republic's signature Sloan fabric. The Company informed that the limited-edition collection launches exclusively at select Banana Republic locations worldwide and online in early August 2014. The full analyst notes on Gap are available to download free of charge at:

http://www.analystsreview.com/1548-GPS-24Apr2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.analystsreview.com/


SOURCE Analysts Review

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.